Insufficient scRNA-seq data for expression of MAGEC2 at single-cell level.
Insufficient scRNA-seq data for expression of MAGEC2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 1% | 0.18 | 11 / 1809 | 44% | 88.63 | 209 / 472 |
liver | 1% | 0.29 | 2 / 226 | 21% | 13.37 | 87 / 406 |
lung | 0% | 0.10 | 1 / 578 | 12% | 8.80 | 139 / 1155 |
ovary | 1% | 0.18 | 1 / 180 | 9% | 6.78 | 40 / 430 |
bladder | 0% | 0 | 0 / 21 | 9% | 5.11 | 47 / 504 |
esophagus | 1% | 0.45 | 16 / 1445 | 8% | 5.97 | 15 / 183 |
breast | 1% | 0.33 | 5 / 459 | 5% | 2.04 | 56 / 1118 |
adrenal gland | 0% | 0.10 | 1 / 258 | 5% | 2.97 | 12 / 230 |
uterus | 1% | 0.31 | 1 / 170 | 5% | 3.41 | 23 / 459 |
stomach | 0% | 0 | 0 / 359 | 5% | 3.49 | 13 / 286 |
prostate | 2% | 1.08 | 4 / 245 | 2% | 0.60 | 11 / 502 |
intestine | 0% | 0.01 | 1 / 966 | 3% | 2.19 | 16 / 527 |
pancreas | 0% | 0 | 0 / 328 | 2% | 3.93 | 3 / 178 |
kidney | 0% | 0 | 0 / 89 | 2% | 1.66 | 14 / 901 |
brain | 0% | 0.15 | 11 / 2642 | 1% | 0.29 | 5 / 705 |
thymus | 1% | 0.52 | 7 / 653 | 0% | 0 | 0 / 605 |
muscle | 1% | 0.39 | 7 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 1% | 0.37 | 8 / 929 | 0% | 0 | 0 / 0 |
adipose | 0% | 0.53 | 6 / 1204 | 0% | 0 | 0 / 0 |
spleen | 0% | 0.06 | 1 / 241 | 0% | 0 | 0 / 0 |
heart | 0% | 0.02 | 1 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0.01 | 1 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0030163 | Biological process | protein catabolic process |
GO_0051443 | Biological process | positive regulation of ubiquitin-protein transferase activity |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0005515 | Molecular function | protein binding |
Gene name | MAGEC2 |
Protein name | Melanoma-associated antigen C2 (Cancer/testis antigen 10) (CT10) (Hepatocellular carcinoma-associated antigen 587) (MAGE-C2 antigen) (MAGE-E1 antigen) |
Synonyms | HCA587 MAGEE1 |
Description | FUNCTION: Proposed to enhance ubiquitin ligase activity of RING-type zinc finger-containing E3 ubiquitin-protein ligases. In vitro enhances ubiquitin ligase activity of TRIM28 and stimulates p53/TP53 ubiquitination in presence of Ubl-conjugating enzyme UBE2H leading to p53/TP53 degradation. Proposed to act through recruitment and/or stabilization of the Ubl-conjugating enzymes (E2) at the E3:substrate complex. . |
Accessions | ENST00000247452.4 Q9UBF1 |